Suppr超能文献

泪腺肿瘤的流行病学和治疗:基于人群的队列分析。

Epidemiology and treatment of lacrimal gland tumors: a population-based cohort analysis.

机构信息

Department of Head and Neck Surgery, David Geffen School of Medicine at University of California, Los Angeles.

medical student at David Geffen School of Medicine at University of California, Los Angeles.

出版信息

JAMA Otolaryngol Head Neck Surg. 2014 Dec;140(12):1110-6. doi: 10.1001/jamaoto.2014.2846.

Abstract

IMPORTANCE

Primary tumors of the lacrimal gland are rare and are associated with substantial morbidity and mortality. The literature regarding these tumors is limited to case series and case reports.

OBJECTIVE

To examine the incidence, treatment, and overall survival (OS) and disease-specific survival (DSS) of patients with cancer of the lacrimal gland.

DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database to identify patients with primary tumors of the lacrimal gland from 1973 to 2010.

MAIN OUTCOMES AND MEASURES

Overall survival and DSS.

RESULTS

A total of 321 patients with nonlymphoid tumors of the lacrimal gland were identified. The most common histological subtypes were adenoid cystic carcinoma (ACC) (32.1%) and squamous cell carcinoma (SCC) (29.9%). Survival analysis revealed a 5-year OS and DSS for all lacrimal gland tumors of 60% and 75%, respectively. On univariate analysis, low tumor grade (P = .04) and surgical treatment (P < .001) were associated with significantly better OS. For ACC tumors, surgery (P = .009), but not radiotherapy (P = .44), was found to significantly improve OS. For SCC tumors, surgical treatment significantly improved both OS (P < .001) and DSS (P = .004); radiation therapy also significantly improved OS (P = .03). Using a multivariable analysis model, age (hazard ratio [HR], 1.03 [95% CI, 1.01-1.04]; P < .001), surgery (HR, 0.43 [95% CI, 0.25-0.75]; P = .003), and T stage at presentation (HR, 1.18 [95% CI, 1.01-1.37]; P = .03) were found to be independent predictors of OS. For ACC alone, age (HR, 1.04 [95% CI, 1.02-1.06]; P < .001) and surgery (HR, 0.35 [95% CI, 0.13-0.91]; P = .03) were independent predictors of OS. For SCC, age (HR, 1.05 [95% CI, 1.02-1.09]; P = .005), surgical resection (HR, 0.31 [95% CI, 0.12-0.83]; P = .02), and radiation therapy (HR, 0.33 [95% CI, 0.14-0.80]; P = .01) were independent predictors of OS.

CONCLUSIONS AND RELEVANCE

Our study demonstrates that ACC is the most common malignant epithelial neoplasm of the lacrimal gland. Determinants of survival for tumors of the lacrimal gland include age at diagnosis and surgical therapy. Radiation therapy is associated with improved DSS in SCC but not in ACC.

摘要

重要性

泪腺原发性肿瘤较为罕见,与较高的发病率和死亡率相关。目前,关于此类肿瘤的文献主要为病例系列和病例报告。

目的

研究泪腺癌患者的发病率、治疗方法以及总生存率(OS)和疾病特异性生存率(DSS)。

设计、设置和参与者:本研究使用监测、流行病学和最终结果(SEER)数据库进行了一项基于人群的队列分析,以确定 1973 年至 2010 年期间患有泪腺原发性肿瘤的患者。

主要结局和测量指标

OS 和 DSS。

结果

共确定了 321 例非淋巴样泪腺肿瘤患者。最常见的组织学亚型为腺样囊性癌(ACC)(32.1%)和鳞状细胞癌(SCC)(29.9%)。生存分析显示,所有泪腺癌的 5 年 OS 和 DSS 分别为 60%和 75%。单因素分析显示,肿瘤分级低(P = .04)和手术治疗(P < .001)与 OS 显著改善相关。对于 ACC 肿瘤,手术(P = .009)而非放疗(P = .44)可显著改善 OS。对于 SCC 肿瘤,手术治疗可显著改善 OS(P < .001)和 DSS(P = .004);放疗也显著改善 OS(P = .03)。多变量分析模型显示,年龄(风险比 [HR],1.03 [95% CI,1.01-1.04];P < .001)、手术(HR,0.43 [95% CI,0.25-0.75];P = .003)和就诊时的 T 分期(HR,1.18 [95% CI,1.01-1.37];P = .03)是 OS 的独立预测因素。对于单纯 ACC,年龄(HR,1.04 [95% CI,1.02-1.06];P < .001)和手术(HR,0.35 [95% CI,0.13-0.91];P = .03)是 OS 的独立预测因素。对于 SCC,年龄(HR,1.05 [95% CI,1.02-1.09];P = .005)、手术切除(HR,0.31 [95% CI,0.12-0.83];P = .02)和放疗(HR,0.33 [95% CI,0.14-0.80];P = .01)是 OS 的独立预测因素。

结论和相关性

本研究表明,ACC 是最常见的泪腺恶性上皮性肿瘤。影响泪腺癌患者生存的因素包括诊断时的年龄和外科治疗。放疗可提高 SCC 的 DSS,但不能提高 ACC 的 DSS。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验